- Elite Trade Club
- Posts
- This 90 Cent Biotech Is Up 123%
This 90 Cent Biotech Is Up 123%
Good Afternoon!
Hey, everyone. It's Adam from Elite Trade Club.
Here’s what moved the market today.
Markets 📈
Major indexes were flat for the most part, with the Russel 2k experiencing a 1% drop.
|
|
10 East is a co-investment platform where sophisticated investors access private markets alongside a veteran team with a decade+ track record of strong performance.
Members can participate on a deal-by-deal basis - benefiting from institutional resources, sourcing, vetting, and ongoing monitoring.
» Want an Ad-Free Experience + Top Growth Stock Picks? Upgrade Now!
Market-Moving News 📈
Tesla Soars as Morgan Stanley Names It Top U.S. Auto Pick
Tesla (TSLA) shares surged 6.3% on Monday after Morgan Stanley elevated the electric vehicle giant to its "top pick" in the U.S. automotive sector, ousting Ford (F).
The brokerage firm believes Tesla's energy division holds the potential to surpass the value of its auto business in the future, particularly as investors increasingly prioritize companies addressing climate change.
Morgan Stanley also foresees Tesla solidifying its position as a leader in zero-emission vehicle credit revenue, anticipating that the company could capture up to half of the market.
This segment, which garnered approximately $2,000 per unit in the second quarter, represents a 100% margin opportunity that may not be fully recognized by investors yet.
Despite this positive outlook, Tesla recently posted its lowest profit margin in over five years and missed Wall Street's earnings expectations for the second quarter.
The company, led by Elon Musk, has been offering significant discounts to boost vehicle sales amid waning demand.
Morgan Stanley analysts also expressed concerns about Tesla's ability to commercialize its autonomous driving technology in China and the broader future of EV demand.
The firm has been under regulatory scrutiny regarding the safety of its self-driving features.
Investors are eagerly anticipating Tesla's upcoming robotaxi launch event, which has been rescheduled from August to October for further refinements.
On the flip side, Ford's shares fell nearly 2% on Monday, following a 20% decline last week after the company reported lower-than-expected second-quarter profits.
Ford continues to face challenges with quality-related costs and intense competition in the EV market.
Top Winners and Losers 🔥
Lipella Pharmaceuticals Inc [LIPO] $0.9 (+123%)
LIPO initiated phase 2 trials for LP-310, a proprietary liposomal-tacrolimus oral rinse formulation of the company’s lead candidate LP-10 for hemorrhagic cystitis
2U Inc [TWOU] $2.65 (+112%)
It is unclear why the stock rallied to much today. The company filed for bankruptcy last week and may just be correcting from the massive drop it experienced.
Meta Data Limited ADR [AIU] $4.56 (+87%)
This online education stock rallied today after a 5 - 1 reversal split. Reverse splits are usually a negative thing and are done to regain share price compliance but investors seem to be happy with the development.
Cognition Therapeutics Inc [CGTX] $1.33 (44%)
CGTX is falling on negative clinical trial data.
GRI Bio Inc [GRI] $.82 (35%)
It is not clear why this biotech is bleeding today but many online are speculating that upcoming clinical date wont be good.
vTv Therapeutics Inc [VTVT] $16.00 (25%)
The drop in this stock was caused by a hold that was put on one of its clinical programs by the FDA.
That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!
Thanks for reading. I'll see you at the next open!
Best Regards,
— Adam G.
Elite Trade Club
Text ELITESTOCKS to 47121 or click here to get our alerts on your mobile device, and never miss another fast-moving stock!
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.
A radical new A.I. development is about to blindside millions of Americans.
This early A.I. pioneer just issued an urgent warning explaining everything.